Bilingual

Reverse Engineering the source code of the BioNTech/Pfizer SARS-CoV-2 Vaccine - Bert Hubert's writings
a day ago
- The BioNTech/Pfizer vaccine contains mRNA source code of 4284 characters, with each character weighing about 0.53·10⁻²¹ grams, and a 30-microgram dose includes approximately 6·10¹⁶ characters or 13 trillion repetitions of the same sequence.
- The mRNA vaccine teaches the immune system to fight SARS-CoV-2 by instructing cells to produce the Spike protein, using a 'cap' (GA nucleotides) to mimic natural mRNA, a 5' untranslated region (UTR) for ribosome binding, and a signal peptide for protein localization.
- Key modifications include replacing uracil (U) with 1-methyl-3'-pseudouridylyl ( обозначено как ) to evade immune detection, and codon optimization to add more guanine (G) and cytosine (C) for enhanced protein production.
- Two proline substitutions in the Spike protein stabilize it in a pre-fusion configuration, improving vaccine efficacy, and the vaccine uses a poly-A tail with a linker to protect mRNA from degradation.
- The vaccine's source code includes a 3' untranslated region from AES and 12S ribosomal RNA for stability and expression, and ends with two stop codons for efficient protein translation.
Dekonstruktion des Programmcodes des BioNTech/Pfizer SARS-CoV-2 Impfstoffes - Bert Hubert's writings
a day ago
- The BioNTech/Pfizer SARS-CoV-2 mRNA vaccine (BNT162b2) consists of a digital code of 4284 characters, produced by a DNA printer and delivered as RNA in a lipid package.
- RNA is a fragile, RAM-like version of DNA; the vaccine's need for ultra-cold storage is due to RNA's instability.
- The vaccine code uses modified 'U' bases (1-Methyl-3'-Pseudouridylyl) to evade the immune system, a trick akin to cybersecurity bypassing firewalls.
- The 5' untranslated region (UTR) optimizes ribosome docking and protein translation, based on α-globin genome for high efficiency.
- A signal peptide directs the Spike protein to leave the cell via the endoplasmic reticulum, with codon optimization (more C and G bases) to enhance production.
- The Spike protein coding region features two proline substitutions that lock the protein in its active form, increasing vaccine efficacy against the actual virus.
- The 3' UTR and poly(A) tail of the mRNA enhance stability and translation efficiency, with a proprietary linker sequence for optimization.
- All modifications (codon optimization, U replacement, proline changes) are designed to increase RNA stability, evade immune detection, and produce a stable, immunogenic Spike protein.
Ingegnerizzazione inversa del Codice Sorgente del Vaccino BioNTech/Pfizer - Bert Hubert's writings
a day ago
- The mRNA vaccine code consists of 4284 characters, starting with 'GA' as a cap for legitimacy.
- RNA is fragile and requires ultra-low temperature storage, similar to RAM in computers.
- The vaccine uses 1-methyl-3'-pseudouridine (Ψ) instead of uracil to evade the immune system.
- The 5' untranslated region (UTR) provides a ribosome landing zone and is optimized for high protein expression.
- A signal peptide derived from the virus directs the spike protein to the endoplasmic reticulum.
- Codon optimization increases G and C content to enhance translation efficiency without changing amino acids.
- Two proline substitutions (K→P and V→P) stabilize the spike protein in its pre-fusion conformation, essential for immune response.
- The 3' UTR and poly-A tail (with a mysterious linker) improve mRNA stability and protein expression.
- The vaccine teaches the immune system to recognize the SARS-CoV-2 spike protein without causing disease.
Een inkijkje in de broncode van het BioNTech/Pfizer SARS-CoV-2-vaccin - Bert Hubert's writings
a day ago
- The mRNA vaccine contains genetic code that instructs cells to produce the SARS-CoV-2 spike protein.
- The mRNA is modified with pseudouridine (1-methyl-3'-pseudouridylyl) to evade immune detection and enhance stability.
- The code includes a 5' cap, optimized 5' and 3' untranslated regions (UTRs), a signal peptide, and a codon-optimized spike protein sequence.
- Two proline substitutions in the spike protein stabilize it in the prefusion conformation, improving immune response.
- Codon optimization increases G and C content for higher protein expression efficiency.
- The poly-A tail has a unique linker sequence, possibly for further optimization.
- The vaccine leverages decades of research and is 95% effective.
Een inkijkje in de broncode van het BioNTech/Pfizer SARS-CoV-2-vaccin - Bert Hubert's writings
a day ago
- The mRNA vaccine contains a digital code (A, C, G, U) that instructs cells to produce the SARS-CoV-2 spike protein, training the immune system without causing disease.
- Key components include a 5' cap for legitimacy, a 5' untranslated region (UTR) for ribosome binding, a signal peptide for protein localization, and a codon-optimized spike protein with two proline substitutions to stabilize its prefusion shape.
- The vaccine uses 1-methyl-3'-pseudouridylyl (Ν) instead of uracil to evade the immune system, and codon optimization adds more C and G bases for increased protein production.
- The 3' UTR and poly-A tail (with a linker) enhance mRNA stability and translation efficiency, while the entire sequence is about 4284 nucleotides long, with each dose containing trillions of copies.
Ingeniería inversa del código fuente de la vacuna de BioNTech/Pfizer para el SARS-CoV-2 - Bert Hubert's writings
a day ago
- The article explains the mRNA vaccine's digital source code, consisting of 4284 characters that are translated into RNA molecules.
- Key components include a CAP, 5' untranslated region (UTR), optimized signal peptide, codon-optimized spike protein with two proline substitutions, 3' UTR, and a poly-A tail with a mysterious linker.
- Modifications like replacing U with 1-methyl-3'-pseudouridine (Ψ) evade the immune system, while codon optimization adds G and C for stability and higher protein expression.
- The two proline substitutions stabilize the spike protein in its prefusion conformation, crucial for effective immune response.
- The vaccine trains the immune system by having cells produce SARS-CoV-2 spike proteins without causing disease.
- Analogies between computer code and genetic code are drawn throughout, highlighting similarities in processing and optimization.
Reverse Engineering Source Code of the Biontech Pfizer Vaccine: Part 2 - Bert Hubert's writings
a day ago
- The vaccine mRNA has been optimized by changing specific RNA codons (e.g., UUU to UUC) to increase G and C content for improved efficiency.
- A leaderboard tracks algorithms that attempt to reverse-engineer the optimization, with current best achieving ~79.5% codon match using static mapping.
- The challenge is to design an algorithm that transforms wild-type viral RNA into the BNT162b2 vaccine RNA without peeking at the vaccine sequence.
- Factors influencing optimization include GC ratio management, codon frequency in human cells, and RNA folding for stability and immune evasion.
- The algorithm should only use original virus RNA as input, and participants can submit their code for inclusion in the leaderboard.
Reverzni inženiring izvorne kode cepiva BioNTech/Pfizer proti SARS-CoV-2 - Bert Hubert's writings
a day ago
- The BioNTech/Pfizer mRNA vaccine contains a digital code of 4284 letters that is synthesized into DNA, then RNA, and packaged into lipid nanoparticles for delivery.
- The mRNA uses a 5' cap (starting with GA) and 5' UTR to initiate translation, with modifications like replacing U with 1-methyl-3'-pseudouridine (Ψ) to avoid immune detection.
- Codon optimization replaces many bases with G and C to increase protein production efficiency, while maintaining the same amino acid sequence as the virus.
- Two proline substitutions (K→P and V→P) in the spike protein stabilize its prefusion conformation, making the vaccine effective.
- The 3' UTR and poly-A tail (with an internal linker) enhance mRNA stability and protein expression, with the poly-A tail protecting against degradation.
Analiza izvornog kôda vakcine BioNTech-Pfizer SARS-CoV-2 - Bert Hubert's writings
a day ago
- The BioNTech/Pfizer vaccine is based on a 4284-character digital code that is synthesized into DNA and later converted into RNA for injection.
- mRNA vaccines teach the immune system to recognize the SARS-CoV-2 spike protein without causing illness, using a highly precise genetic approach.
- The vaccine uses a modified nucleotide, 1-methyl-3'-pseudouridine, to avoid immune detection while remaining functional in cells.
- The vaccine code includes a 5' untranslated region (UTR) for ribosome binding and a signal peptide to direct the spike protein to the endoplasmic reticulum.
- Most codons in the vaccine are synonymously optimized to include more G and C nucleotides, enhancing protein production efficiency.
- Two proline substitutions (K and V to P) in the spike protein stabilize it in a prefusion conformation, boosting vaccine effectiveness.
- The vaccine ends with a poly-A tail, including 30 A's, a 10-nucleotide linker, and 70 more A's, to protect mRNA from degradation.
- The entire vaccine is a codon-optimized, modified RNA sequence designed to produce a stable spike protein and trigger a strong immune response.
The CureVac Vaccine, and a brief tour through some of the wonders of nature - Bert Hubert's writings
a day ago
- CureVac's vaccine uses unmodified mRNA, unlike BioNTech/Moderna which use modified nucleosides to evade immune detection.
- CureVac employs alternative strategies: a minimal 5' UTR with technical artifacts, a poly(C) stretch for stability, and a histone stem-loop for longevity.
- The vaccine's mRNA has high GC content (63%) and extensive codon modifications to enhance stability and protein expression.
- Unmodified mRNA may act as an adjuvant, potentially boosting immune response, but early trial results (June 16 update) were disappointing.
- The vaccine is designed for refrigerator stability, maintaining efficacy at regular temperatures.
Sadly, You Can't Print Your Own (safe) mRNA Vaccine - Bert Hubert's writings
a day ago
- mRNA sequences of some vaccines are publicly available, but there is no technology to directly 'print' mRNA.
- Producing mRNA requires complex biological processes involving bacteria and viral enzymes, plus filtration to remove harmful double-stranded RNA.
- mRNA must be packaged in specially designed lipid nanoparticles (LNPs), with specific lipids and proprietary mixing techniques.
- Multiple quality control steps are needed to ensure code correctness, capping, concentration, and sterility.
- All production must occur in a fully sterile environment to avoid contamination.
- While future automation might simplify some steps, currently printing safe mRNA vaccines at home is impossible.
mRNA vaccine targeting tick proteins induces tick resistance in guinea pigs
16 days ago
- IscREAM is a powerful tool for mapping immune responses to many tick proteins simultaneously.
- 52 patient sera were tested; 33 recognized an average of 8 antigens each, totaling 177 antigens.
- Serum from a reportedly resistant human transferred to guinea pigs confirmed tick resistance.
- Guinea pigs vaccinated with an mRNA vaccine encoding 25 tick cement antigens showed resistance.
- Immune responses in Lyme disease patients varied, requiring more work to identify biomarkers.
- An anti-tick vaccine based on cement targets is promising, with potential availability in 5-10 years.
- Research was supported by NIH and other foundations, with disclaimers on official views.

Hasty Briefsbeta

mrna vaccine

Reverse Engineering the source code of the BioNTech/Pfizer SARS-CoV-2 Vaccine - Bert Hubert's writings

Dekonstruktion des Programmcodes des BioNTech/Pfizer SARS-CoV-2 Impfstoffes - Bert Hubert's writings

Ingegnerizzazione inversa del Codice Sorgente del Vaccino BioNTech/Pfizer - Bert Hubert's writings

Een inkijkje in de broncode van het BioNTech/Pfizer SARS-CoV-2-vaccin - Bert Hubert's writings

Een inkijkje in de broncode van het BioNTech/Pfizer SARS-CoV-2-vaccin - Bert Hubert's writings

Ingeniería inversa del código fuente de la vacuna de BioNTech/Pfizer para el SARS-CoV-2 - Bert Hubert's writings

Reverse Engineering Source Code of the Biontech Pfizer Vaccine: Part 2 - Bert Hubert's writings

Reverzni inženiring izvorne kode cepiva BioNTech/Pfizer proti SARS-CoV-2 - Bert Hubert's writings

Analiza izvornog kôda vakcine BioNTech-Pfizer SARS-CoV-2 - Bert Hubert's writings

The CureVac Vaccine, and a brief tour through some of the wonders of nature - Bert Hubert's writings

Sadly, You Can't Print Your Own (safe) mRNA Vaccine - Bert Hubert's writings

mRNA vaccine targeting tick proteins induces tick resistance in guinea pigs